In December, the US Federal Vaccine Advisory Committee released a statement stating that the vaccines vaccine would be tested in the US in the coming months and that the US was “currently evaluating the vaccine as it relates to its safety and effectiveness”.

In response to the US announcement, several countries have announced they would not vaccinate children with the HPV vaccine.

On March 4th, Spain and Portugal both announced they were cancelling their vaccine schedules, while a third country, India, has announced that it would not begin vaccinating its children.

Meanwhile, the UK, Germany, France and Austria announced they had suspended their HPV vaccines.

According to the BBC, there are currently five vaccine trials currently being conducted in India.

India has a population of approximately 2.2 billion people and over 1.5 million deaths each year from HPV.

While the country has the highest rate of HPV vaccination in the world, it still has a vaccine shortage, as the World Health Organization has warned that India’s vaccine has been “over-prescribed” in recent years, with the vaccine being “oversold” by pharmaceutical companies.

According the WHO, India is currently the third-largest HPV vaccine producer, and is currently making a vaccine of their own.

While there is no word on whether the vaccines will be ready to use by the end of this year, India has stated that it will be able to produce the vaccine within three years.